Company Filing History:
8 out of 8 
1 out of 1 
1 out of 4 Years Active: 2014-2025
Title: Raúl Insa Boronat: Innovator in Pharmaceutical Treatments
Introduction
Raúl Insa Boronat is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of rare diseases. With a total of 10 patents to his name, his work has the potential to impact many lives.
Latest Patents
One of his latest patents involves the use of triamterene or nolatrexed for the treatment of phenylketonuria. This invention relates to a compound selected from a group that includes nolatrexed, triamterene, sultopride, and hydrastinine, or a pharmaceutically acceptable salt thereof. The patent outlines the use of these compounds in the manufacture of a medicament for the treatment and prevention of phenylketonuria.
Another significant patent focuses on sustained release compositions comprising micronized tolcapone. This invention describes a sustained release tablet that includes micronized tolcapone, a release retardant, and a binder. The tablet is intended for the prevention and treatment of transthyretin-associated amyloidosis, providing a method for administering an effective amount of the tablet to subjects in need.
Career Highlights
Raúl has worked with Som Innovation Biotech, S.L. and Som Innovation Biotech, S.A., where he has contributed to various innovative projects in the pharmaceutical sector. His expertise in drug formulation and development has been instrumental in advancing therapeutic options for patients.
Collaborations
Throughout his career, Raúl has collaborated with notable professionals in the field, including Marc Centellas Casado and Nuria Reig Bolaño. These collaborations have fostered a creative environment for innovation and have led to the development of impactful pharmaceutical solutions.
Conclusion
Raúl Insa Boronat is a distinguished inventor whose work in pharmaceuticals continues to pave the way for new treatments. His patents reflect a commitment to improving healthcare outcomes for patients with rare diseases.